Zentalis Pharmaceuticals Inc (ZNTL)
3.23
+0.05
(+1.57%)
USD |
NASDAQ |
Nov 22, 16:00
3.24
+0.01
(+0.31%)
Pre-Market: 20:00
Zentalis Pharmaceuticals Shareholders Equity (Quarterly): 354.33M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 354.33M |
| June 30, 2024 | 382.58M |
| March 31, 2024 | 458.77M |
| December 31, 2023 | 437.28M |
| September 30, 2023 | 481.77M |
| June 30, 2023 | 523.14M |
| March 31, 2023 | 385.49M |
| December 31, 2022 | 433.80M |
| September 30, 2022 | 428.50M |
| June 30, 2022 | 472.49M |
| Date | Value |
|---|---|
| March 31, 2022 | 315.30M |
| December 31, 2021 | 363.95M |
| September 30, 2021 | 393.43M |
| June 30, 2021 | 223.84M |
| March 31, 2021 | 268.39M |
| December 31, 2020 | 308.58M |
| September 30, 2020 | 341.06M |
| June 30, 2020 | 213.22M |
| March 31, 2020 | -95.90M |
| December 31, 2019 | -80.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-95.90M
Minimum
Mar 2020
523.14M
Maximum
Jun 2023
330.50M
Average
373.27M
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
| Myomo Inc | 9.292M |
| Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 450.66M |
| Total Liabilities (Quarterly) | 96.33M |